Anti-TNF Therapy and Malignancy – A Critical Review

by Roger B Cohen, Karen A Dittrich
Published 2001-01-01

Immunotherapy for head and neck cancer: latest developments and clinical potential

by Joshua M. Bauml, Roger B. Cohen, Charu Aggarwal
Published 2016-05-01

The contribution of cetuximab in the treatment of recurrent and/or metastatic head and neck cancer

by Mohamedtaki A Tejani, Roger B Cohen, Ranee Mehra
Published 2010-06-01

Immune Checkpoint Inhibitor–Related Cardiovascular Toxicity in Lung Cancer

by Lova Sun, MD, Charu Aggarwal, MD, MPH, Roger B. Cohen, MD
Published 2019-12-01

Treatment of corticosteroid refractory immune checkpoint inhibitor myocarditis with Infliximab: a case series

by Robert S. Zhang, Allison Padegimas, Kathleen M. Murphy, Peter T. Evans, Carli J. Peters, Christopher M. Domenico, Mahesh K. Vidula, Paul J. Mather, Marisa Cevasco, Roger B. Cohen, Joseph R. Carver, Rupal P. O’Quinn
Published 2021-03-01

Immune Therapy Targeting E6/E7 Oncogenes of Human Paillomavirus Type 6 (HPV-6) Reduces or Eliminates the Need for Surgical Intervention in the Treatment of HPV-6 Associated Recurre...

by Charu Aggarwal, Roger B. Cohen, Matthew P Morrow, Kimberly A Kraynyak, Albert J Sylvester, Jocelyn Cheung, Kelsie Dickerson, Veronique Schulten, Dawson Knoblock, Elisabeth Gillespie, Joshua M. Bauml, Jian Yan, Malissa Diehl, Jean Boyer, Michael Dallas, J. Joseph Kim, David B Weiner, Jeffrey M. Skolnik
Published 2020-01-01

Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma.

by Bert H O'Neil, John M Wallmark, David Lorente, Elena Elez, Judith Raimbourg, Carlos Gomez-Roca, Samuel Ejadi, Sarina A Piha-Paul, Mark N Stein, Albiruni R Abdul Razak, Katia Dotti, Armando Santoro, Roger B Cohen, Marlena Gould, Sanatan Saraf, Karen Stein, Sae-Won Han
Published 2017-01-01